Medical devices, healthcare technology and the business of care
TENDER NOTICE · 809017-2026

Italy – Various medicinal products – FORNITURA del farmaco ENHERTU*INF 1FL POLV 100 MG, principio attivo trastuzumab deruxtecan AIC: 049328014 Ditta Daiichi Sankyo Italia S.p.A., per 12 mesi Codice Pratica 070426ADas

Azienda Unità Sanitaria Locale Umbria n. 2 · Italy · TED notice published Nov 20, 2026

What this procurement record shows

Azienda Unità Sanitaria Locale Umbria n. 2 is the named purchasing organization in TED notice 809017-2026. The notice invites a procurement response; it does not establish a contract award.

The normalized category is laboratory and diagnostics. Official laboratory classification or explicit laboratory-equipment description. Separate lot-to-supplier associations are shown only when the source identifies them explicitly.

Product or service scope in the source

FORNITURA del farmaco ENHERTU*INF 1FL POLV 100 MG, principio attivo trastuzumab deruxtecan AIC: 049328014 Ditta Daiichi Sankyo Italia S.p.A., per 12 mesi Codice Pratica 070426ADas

The title and scope above retain the source wording. A specific model, catalog number or manufacturer should be treated as established only if it appears in the original notice or its documents.

Dates and procedure

Record type
Tender notice
Status
Not established
Publication date
Nov 20, 2026
Tender deadline
Not reported in normalized fields
Procedure / parent identifier
02500a0f-9490-42e7-8b97-0992846e3409
Framework agreement
Not established from available fields

Check the original notice for deadline time, timezone, eligibility, amendments and the current submission route. A calendar date alone cannot confirm whether submissions are still accepted.

Disclosed financial values

MeasureAmountScopeSource field
Estimated value€571,138.60ProcedureTED search API estimated-value-proc

An estimated tender value and a framework maximum are different from an award value or actual purchasing volume. Values are not converted between currencies, and no unit price is calculated from aggregate contract totals.

Source and update history

Open the official TED notice

Source identifier
809017-2026
Retrieved
Nov 20, 2026
Source update
Not separately reported
Material data change recorded
Nov 20, 2026

Official source fields are shown separately from MedtechLedger’s explanation. Retrieval is not the publication date.

809017-2026: Italy – Various medicinal products – FORNITURA del farmaco ENHERTU*INF 1FL POLV 100 MG, principio attivo trastuzumab deruxtec | MedtechLedger